Potent antibacterial activity of Terminalia chebula-based herbal soap formulation against propionibacterium acnes and its cytotoxic evaluation on human skin fibroblast cells

Mukhtar  Almukashir; Shamsi Saad  Shamsi; Salahaldin  Alfurjany; Enas  Ali; Heba Zidan

doi:10.18231/j.joapr.2023.11.5.1.8

Authors

Mukhtar Almukashir Department of Botany, Research Laboratory, Faculty of Science, Sebha University, Sebha
Shamsi Saad Shamsi Department of Microbiology, Libyan Medical Research Center, Sebha Department of Microbiology, Faculty of Science, Sebha University, Sebha
Salahaldin Alfurjany Department of Botany, Research Laboratory, Faculty of Science, Sebha University, Sebha
Enas Ali Department of Microbiology, Libyan Medical Research Center, Sebha
Heba Zidan Department of Microbiology, Libyan Medical Research Center, Sebha

DOI:

https://doi.org/10.18231/j.joapr.2023.11.5.1.8

Keywords:

Terminalia chebula, Herbal soap, Propinobacterium, Human Skin Fibroblast Cells

Abstract

Background: Recently, many approaches have been conducted in natural skin healthcare, with herbal remedies gaining prominence due to their perceived efficacy and fewer side effects. Herbal soaps, in particular, are noted for their antimicrobial, anti-inflammatory, and antioxidant properties, making them appealing for acne-causing bacteria such as Propionibacterium acnes, Terminalia chebula, a medicinal plant with a rich history of traditional medicinal properties, including antibacterial effects. However, limited information exists on its activity against acne-causing bacteria and its cytotoxicity on human skin cells. Methods: Our study demonstrated the anti-propionibacterium activity using a novel Terminalia chebula herbal soap formulation (TC-HSF), and to determine its cytotoxicity on Human skin fibroblast cells, Terminalia chebula aqueous extract was used to make herbal soap, the antibacterial activity was performed against wild isolated propionibacterium acne strain using well-diffusion method, MIC and time-kill Kinetics, several concentrations were evaluated for cytotoxicity on Human skin fibroblast cell lines.

Results Our findings indicate a potent activity of TC-HSF against P.acne at 0.18mg\ml with lower CFU\ml in tested intervals and high cell viability 98%, IC₅₀Value was 50mg\ml. Conclusion: Our study highlights the promising antibacterial efficacy of TC-HSF against Propionibacterium acnes and its cytotoxic effects on human skin fibroblast cells. The research adds valuable insights into the potential of TC-HSF for acne management and underscores the importance of dosage considerations in the formulation of herbal soap products.

Downloads

Download data is not yet available.

References

Heng AHS, Chew FT. Systematic review of the epidemiology of acne vulgaris. Sci Rep, 10, 5754 (2020).

Kamra M, Diwan A. Acne: current perspective. Journal of Applied Pharmaceutical Research, 5, 1–7 (2017).

Cong T-X, Hao D, Wen X, Li X-H, He G, Jiang X. From pathogenesis of acne vulgaris to anti-acne agents. Arch Dermatol Res, 311, 337–49 (2019).

El-Tonsy TMK, Mohammed MA, Hamed YAE-E, Tawfik SH. Bacteriological study of acne vulgaris in Cairo Egypt. Egypt J Hosp Med, 72, 5203–9 (2018).

O’Neill AM, Gallo RL. Host-microbiome interactions and recent progress into understanding the biology of acne vulgaris. Microbiome, 6, 1–16 (2018).

Walsh TR, Efthimiou J, Dréno B. Systematic review of antibiotic resistance in acne: an increasing topical and oral threat. Lancet Infect Dis, 16, e23–33 (2016).

Fabbrocini G, Annunziata MC, D’arco V, De Vita V, Lodi G, Mauriello MC, Pastore F, Monfrecola G. Acne scars: pathogenesis, classification and treatment. Dermatol Res Pract, 2010, (2010).

Ak M. A comprehensive review of acne vulgaris. J. Clin. Pharm, 1, 17–45 (2019).

Mazzarello V, Donadu MG, Ferrari M, Piga G, Usai D, Zanetti S, Sotgiu MA. Treatment of acne with a combination of propolis, tea tree oil, and Aloe vera compared to erythromycin cream: two double-blind investigations. Clin Pharmacol, 175–81 (2018).

Bhairam M, Roy A, Bahadur S, Banafar A, Turkane D. Standardization of herbal medicines–an overview. Journal of Applied Pharmaceutical Research, 1, 14–21 (2013).

Azimi H, Fallah-Tafti M, Khakshur AA, Abdollahi M. A review of phytotherapy of acne vulgaris: Perspective of new pharmacological treatments. Fitoterapia, 83, 1306–17 (2012).

Ashwini R, Gajalakshmi S, Mythili S, Sathiavelu A. Terminalia chebula-a pharmacological review. J Pharm Res, 4, 2884–7 (2011).

Gupta PC. Biological and pharmacological properties of Terminalia chebula Retz.(Haritaki)-An overview. Int J pharm pharm Sci, 4, 62–8 (2012).

Rekha V, Vijayalakshmi D, Kumar N, Manipal S. Anti cariogenic effect of Terminalia chebula. J Clin Diagn Res, 8, ZC51 (2014).

Singh A, Navneet SD, Singh C. Ethnomedicinal utilization and pharmacological benefits of Terminalia chebula: a miracle herbal medicine. Pharmacological Benefits of Natural Products, 85 (2018).

Altememy D, Alizadeh A, Ghasemi S. Current Medical Applications of Terminalia Chebula: An Overview. J Pharm Negat Results, 13, 183–92 (2022).

Sultana B, Anwar F, Ashraf M. Effect of extraction solvent/technique on the antioxidant activity of selected medicinal plant extracts. Molecules, 14, 2167–80 (2009).

Sindhu RK, Chitkara M, Kaur G, Kaur A, Arora S, Sandhu IS. Formulation development and antimicrobial evaluation of polyherbal soap. Plant Arch, 19, 1342–6 (2019).

Salar-Vidal L, Aguilera-Correa JJ, Brüggemann H, Achermann Y, Esteban J. Microbiological Characterization of Cutibacterium acnes Strains Isolated from Prosthetic Joint Infections. Antibiotics, 11, (2022).

Ogidi OI, Tobia PS, Ijere DN, Akpan UM, Omu O, Carbom HE, Iyosayi AR. Investigation of bioactive compounds and antimicrobial sensitivity of pawpaw (Carica papaya) leave extracts against morbific micro-organisms. Journal of Applied Pharmaceutical Research, 10, 21–8 (2022).

Smith KP, Kirby JE. The inoculum effect in the era of multidrug resistance: minor differences in inoculum have dramatic effect on MIC determination. Antimicrob Agents Chemother, 62, 10.1128/aac. 00433-18 (2018).

Soon RL, Lenhard JR, Bulman ZP, Holden PN, Kelchlin P, Steenbergen JN, Friedrich L V, Forrest A, Tsuji BT. Combinatorial pharmacodynamics of ceftolozane-tazobactam against genotypically defined β-lactamase-producing Escherichia coli: insights into the pharmacokinetics/pharmacodynamics of β-lactam–β-lactamase inhibitor combinations. Antimicrob Agents Chemother, 60, 1967–73 (2016).

Salmon AB, Murakami S, Bartke A, Kopchick J, Yasumura K, Miller RA. Fibroblast cell lines from young adult mice of long-lived mutant strains are resistant to multiple forms of stress. American Journal of Physiology-Endocrinology and Metabolism, 289, E23–9 (2005).

Leyden JJ. In vivo antibacterial effects of tretinoin-clindamycin and clindamycin alone on Propionibacterium acnes with varying clindamycin minimum inhibitory. J Drugs Dermatol, 11, 1434–8 (2012).

Elisha IL, Botha FS, McGaw LJ, Eloff JN. The antibacterial activity of extracts of nine plant species with good activity against Escherichia coli against five other bacteria and cytotoxicity of extracts. BMC Complement Altern Med, 17, 1–10 (2017).

Itsarasook K, Ingkaninan K, Chulasiri M, Viyoch J. Antioxidant activity and cytotoxicity to human skin fibroblasts of Terminalia Chebula fruit extract, Proceedings of the 2012 International Conference on Biological and Life Sciences, Singapore, 2012, pp.23–4.

Varma SR, Sivaprakasam TO, Mishra A, Kumar LMS, Prakash NS, Prabhu S, Ramakrishnan S. Protective effects of triphala on dermal fibroblasts and human keratinocytes. PLoS One, 11, e0145921 (2016).

Elizabeth KM. Antimicrobial activity of Terminalia bellerica. Indian journal of clinical Biochemistry, 20, 150–3 (2005).

Mostafa MG, Rahman M, Karim MM. Antimicrobial activity of Terminalia chebula. Int. J Med Arom. Plan, 1, 175–9 (2011).

Bag A, Bhattacharyya SK, Chattopadhyay RR. The development of Terminalia chebula Retz.(Combretaceae) in clinical research. Asian Pac J Trop Biomed, 3, 244–52 (2013).

Suganthy N, Muniasamy S, Archunan G. Safety assessment of methanolic extract of Terminalia chebula fruit, Terminalia arjuna bark and its bioactive constituent 7-methyl gallic acid: In vitro and in vivo studies. Regulatory Toxicology and Pharmacology, 92, 347–57 (2018).